| Jeffrey P Colnes, MD | |
|
12 Hospital Dr, Suite 9, York, ME 03909-1030 | |
| (207) 363-6136 | |
| (207) 363-4863 |
| Full Name | Jeffrey P Colnes |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 40 Years |
| Location | 12 Hospital Dr, York, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649204504 | NPI | - | NPPES |
| 80002088 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 13294 (Maine) | Primary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 8692 (New Hampshire) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| York Hospital | York, ME | Hospital |
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| Wentworth-douglass Hospital | Dover, NH | Hospital |
| Frisbie Memorial Hospital | Rochester, NH | Hospital |
| Anna Jaques Hospital | Newburyport, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| York Hospital | 6406766781 | 169 |
| York Hospital | 6406766781 | 169 |
News Archive
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
The ability of some forms of plankton and bacteria to build an extra natural layer of nanoparticle-like armour has inspired chemists at the University of Warwick to devise a startlingly simple way to give drug bearing polymer vesicles (microscopic polymer based sacs of liquid) their own armoured protection.
After a health insurance change forced Bernard Macon to cut ties with his black doctor, he struggled to find another African American physician online. Then, he realized two health advocates were hiding in plain sight.
Gentel Biosciences, a leader in proteomics profiling tools and RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, jointly announce today their partnership to develop and market RayBiotech's vast collection of antibody array products covering a wide variety of cytokines and other proteins for use with Gentel's APiX chromogenic detection platform.
DENTSPLY International Inc. today announced sales and earnings for the three months and year ended December 31, 2010.
› Verified 5 days ago
| Entity Name | York Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376528398 PECOS PAC ID: 6406766781 Enrollment ID: O20040812001065 |
News Archive
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
The ability of some forms of plankton and bacteria to build an extra natural layer of nanoparticle-like armour has inspired chemists at the University of Warwick to devise a startlingly simple way to give drug bearing polymer vesicles (microscopic polymer based sacs of liquid) their own armoured protection.
After a health insurance change forced Bernard Macon to cut ties with his black doctor, he struggled to find another African American physician online. Then, he realized two health advocates were hiding in plain sight.
Gentel Biosciences, a leader in proteomics profiling tools and RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, jointly announce today their partnership to develop and market RayBiotech's vast collection of antibody array products covering a wide variety of cytokines and other proteins for use with Gentel's APiX chromogenic detection platform.
DENTSPLY International Inc. today announced sales and earnings for the three months and year ended December 31, 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey P Colnes, MD 12 Hospital Dr, Suite 9, York, ME 03909-1030 Ph: (207) 363-6136 | Jeffrey P Colnes, MD 12 Hospital Dr, Suite 9, York, ME 03909-1030 Ph: (207) 363-6136 |
News Archive
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
The ability of some forms of plankton and bacteria to build an extra natural layer of nanoparticle-like armour has inspired chemists at the University of Warwick to devise a startlingly simple way to give drug bearing polymer vesicles (microscopic polymer based sacs of liquid) their own armoured protection.
After a health insurance change forced Bernard Macon to cut ties with his black doctor, he struggled to find another African American physician online. Then, he realized two health advocates were hiding in plain sight.
Gentel Biosciences, a leader in proteomics profiling tools and RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, jointly announce today their partnership to develop and market RayBiotech's vast collection of antibody array products covering a wide variety of cytokines and other proteins for use with Gentel's APiX chromogenic detection platform.
DENTSPLY International Inc. today announced sales and earnings for the three months and year ended December 31, 2010.
› Verified 5 days ago
Catherine Stehman-breen, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 5 Meetinghouse Ln, York, ME 03909 Phone: 207-361-4566 | |
Dr. Evangeline Thibodeau, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2 Hospital Dr, Ste A, York, ME 03909 Phone: 207-351-3530 | |
Dr. Joel William Keenan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Brickyard Ln, Suite Cc, York, ME 03909 Phone: 207-361-4902 Fax: 207-363-2505 | |
Lawrence J Petrovich, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12 Hospital Dr, Suite 9, York, ME 03909 Phone: 207-363-6136 Fax: 207-363-4863 | |
Thomas Gordon Chayka, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 50 Old Post Road, York, ME 03909 Phone: 207-363-5321 Fax: 207-363-7857 | |
Gretchen Volpe, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12 Hospital Dr, Suite B, York, ME 03909 Phone: 207-351-3530 Fax: 207-351-3574 | |
Colleen K. Yavarow, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 127 Long Sands Rd, York, ME 03909 Phone: 207-351-3777 |